Quest Diagnostics (NYSE:DGX) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Quest Diagnostics (NYSE:DGX) reported quarterly earnings results on February 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.42, beating the consensus estimate of $2.35 by $0.07 per share. Revenue came in at $2.8B, beating the estimate of $2.8B.
Quest Diagnostics's stock moved following the earnings release. The stock currently trades at $203.97 with a market capitalization of $20.3B.
Current market data
NYSE · DGX
$240.30
Down: -$2.46 · -1.01%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·
